EA004304B1 - Новые ароматические амиды, замещенные рибозой, способ их получения и их применение в качестве лекарств - Google Patents

Новые ароматические амиды, замещенные рибозой, способ их получения и их применение в качестве лекарств Download PDF

Info

Publication number
EA004304B1
EA004304B1 EA200101100A EA200101100A EA004304B1 EA 004304 B1 EA004304 B1 EA 004304B1 EA 200101100 A EA200101100 A EA 200101100A EA 200101100 A EA200101100 A EA 200101100A EA 004304 B1 EA004304 B1 EA 004304B1
Authority
EA
Eurasian Patent Office
Prior art keywords
formula
methyl
compound
radical
compounds
Prior art date
Application number
EA200101100A
Other languages
English (en)
Russian (ru)
Other versions
EA200101100A1 (ru
Inventor
Жак Демассе
Мишель Клиш
Бранислав Мусицки
Original Assignee
Авентис Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Фарма С.А. filed Critical Авентис Фарма С.А.
Publication of EA200101100A1 publication Critical patent/EA200101100A1/ru
Publication of EA004304B1 publication Critical patent/EA004304B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/075—Benzo[b]pyran-2-ones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EA200101100A 1999-04-19 2000-04-18 Новые ароматические амиды, замещенные рибозой, способ их получения и их применение в качестве лекарств EA004304B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904866A FR2792320B1 (fr) 1999-04-19 1999-04-19 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
PCT/FR2000/000999 WO2000063222A2 (fr) 1999-04-19 2000-04-18 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
EA200101100A1 EA200101100A1 (ru) 2002-04-25
EA004304B1 true EA004304B1 (ru) 2004-02-26

Family

ID=9544554

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200101100A EA004304B1 (ru) 1999-04-19 2000-04-18 Новые ароматические амиды, замещенные рибозой, способ их получения и их применение в качестве лекарств

Country Status (24)

Country Link
US (1) US6579902B1 (cg-RX-API-DMAC7.html)
EP (1) EP1173455A2 (cg-RX-API-DMAC7.html)
JP (1) JP2002542253A (cg-RX-API-DMAC7.html)
KR (1) KR100693258B1 (cg-RX-API-DMAC7.html)
CN (1) CN1213055C (cg-RX-API-DMAC7.html)
AP (1) AP2001002312A0 (cg-RX-API-DMAC7.html)
AU (1) AU769514B2 (cg-RX-API-DMAC7.html)
CA (1) CA2363945A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20013708A3 (cg-RX-API-DMAC7.html)
EA (1) EA004304B1 (cg-RX-API-DMAC7.html)
FR (1) FR2792320B1 (cg-RX-API-DMAC7.html)
HK (1) HK1046690B (cg-RX-API-DMAC7.html)
HU (1) HUP0200778A3 (cg-RX-API-DMAC7.html)
ID (1) ID30562A (cg-RX-API-DMAC7.html)
IL (1) IL146018A0 (cg-RX-API-DMAC7.html)
NO (1) NO320703B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ515108A (cg-RX-API-DMAC7.html)
PL (1) PL354192A1 (cg-RX-API-DMAC7.html)
SK (1) SK14842001A3 (cg-RX-API-DMAC7.html)
TR (1) TR200103009T2 (cg-RX-API-DMAC7.html)
UA (1) UA72919C2 (cg-RX-API-DMAC7.html)
WO (1) WO2000063222A2 (cg-RX-API-DMAC7.html)
YU (1) YU80301A (cg-RX-API-DMAC7.html)
ZA (1) ZA200108627B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
KR100649357B1 (ko) * 2004-05-04 2006-11-24 제일약품주식회사 항염증 활성을 갖는 크로멘-2-온 모핵 히드록사민 산유도체, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
US7622451B2 (en) * 2004-11-03 2009-11-24 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
AU2005301957B2 (en) * 2004-11-03 2012-02-23 Department Of Health And Human Services Novobiocin analogues as anticancer agents
US9120774B2 (en) 2004-11-03 2015-09-01 University Of Kansas Novobiocin analogues having modified sugar moieties
US8212011B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues
US8212012B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues having modified sugar moieties
US7960353B2 (en) * 2007-05-10 2011-06-14 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
WO2010014617A1 (en) * 2008-07-28 2010-02-04 University Of Kansas Heat shock protein 90 inhibitor dosing methods
US20110082098A1 (en) * 2009-09-30 2011-04-07 University Of Kansas Novobiocin analogues and treatment of polycystic kidney disease
MX2025007723A (es) 2018-05-14 2025-08-01 Reata Pharmaceuticals Inc Biarilamidas con grupos de azucar modificados para el tratamiento de enfermedades asociadas con la trayectoria de la proteina de choque de calor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652536A (en) * 1969-06-02 1972-03-28 Upjohn Co Novenamine compounds and derivatives
US3890297A (en) * 1973-03-29 1975-06-17 Upjohn Co Process for n-acylating novenamine

Also Published As

Publication number Publication date
EA200101100A1 (ru) 2002-04-25
SK14842001A3 (sk) 2003-05-02
HK1046690B (zh) 2006-03-10
WO2000063222A2 (fr) 2000-10-26
NO320703B1 (no) 2006-01-16
YU80301A (sh) 2005-07-19
UA72919C2 (uk) 2005-05-16
JP2002542253A (ja) 2002-12-10
FR2792320A1 (fr) 2000-10-20
CZ20013708A3 (cs) 2002-04-17
WO2000063222A3 (fr) 2001-05-31
NO20015058L (no) 2001-12-17
ZA200108627B (en) 2002-10-21
AU769514B2 (en) 2004-01-29
HUP0200778A3 (en) 2003-03-28
CN1213055C (zh) 2005-08-03
KR100693258B1 (ko) 2007-03-13
PL354192A1 (en) 2003-12-29
FR2792320B1 (fr) 2003-05-09
IL146018A0 (en) 2002-07-25
CA2363945A1 (fr) 2000-10-26
ID30562A (id) 2001-12-20
CN1357001A (zh) 2002-07-03
TR200103009T2 (tr) 2002-05-21
US6579902B1 (en) 2003-06-17
KR20020008155A (ko) 2002-01-29
NZ515108A (en) 2004-01-30
HK1046690A1 (en) 2003-01-24
AU4125600A (en) 2000-11-02
AP2001002312A0 (en) 2001-12-31
EP1173455A2 (fr) 2002-01-23
HUP0200778A2 (hu) 2002-07-29
NO20015058D0 (no) 2001-10-18

Similar Documents

Publication Publication Date Title
KR20190026827A (ko) 방향족 아세틸렌 또는 방향족 에틸렌계 화합물, 그의 중간체, 제조 방법, 약물 조성물 및 용도
EP1045856B1 (fr) Nouveaux amides aromatiques, leur procede de preparation et leur application comme medicaments
US11518766B2 (en) Tricyclic compound, preparation method therefor and use thereof
KR20030060944A (ko) 치환된 벤젠 유도체 또는 이의 염
AU769514B2 (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
CN102471363A (zh) 新型黄烷酮衍生物
RU2194052C2 (ru) Производные бензопиран-2-она, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения
KR20240154590A (ko) Lpa 수용체 활성과 연관된 상태를 치료하기 위한 화합물 및 조성물
CN115322077B (zh) 一类烷基酚类化合物及其制备方法
CN114478566A (zh) 消除冬凌草甲素1位羟基的衍生物及用途
DK169517B1 (da) [Aryl](3-pyridinyl)methanon,oximderivater samt fremgangsmåde til fremstilling deraf
EA001733B1 (ru) Производные эритромицина, способ их получения и применение
CN114097804A (zh) 一种二氨基嘧啶类化合物在防治农业病原菌中的用途
JP6422018B2 (ja) 糖脂質代謝異常症処置剤
JP2000109465A (ja) フェニルピラゾ―ル化合物、製法及び抗高脂血症薬
JPH1192493A (ja) リボースにより置換された新規な芳香族誘導体、それらの製造方法及び薬剤としての用途
TW202411231A (zh) 用作泛素-特異性蛋白酶抑制劑的取代嘌呤酮衍生物
AU2002300839B2 (en) Novel aromatic amides, preparation method and application as medicines
TW202421624A (zh) 用作泛素-特異性蛋白酶抑制劑的羰基稠合雜環衍生物
CN120398981A (zh) 具有HIF-1α蛋白抑制活性的红景天苷衍生物及其合成和应用
CN116098910A (zh) 一种用于治疗脑水肿的化合物
CN120267669A (zh) 一种三联苯类化合物及其作为抗炎药物的作用
JP2024538727A (ja) マボリキサフォルの合成およびその中間体
WO2020186504A1 (en) A new type of antitumor compounds: derivatives of 7-propanamide substituted benzoxaborole
JP2000290280A (ja) フェニルアゾール化合物、製造法及び抗高脂血症薬

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU